| abstract |
The invention relates to the use of the MASP-52 protein, from the mucin-associated surface protein (MASP) family, for the diagnosis, treatment and prevention of Chagas disease, including a method for detecting the presence of the T. cruzi parasite in individuals, a method for obtaining data that can be used for diagnosing Chagas disease and a diagnostic kit containing the elements necessary for analysing the quantity of MASP-52 protein in a biological sample. |